Efficacy of Certolizumab Pegol for Psoriasis of the Head and Neck in Two Phase 3 Clinical Trials: CIMPASI-1 and CIMPASI-2. J of Skin 2019, 3, S40. https://doi.org/10.25251/skin.3.supp.40.